SCHEMBL25002364

SCHEMBL25002364

CC1(C)CNCC(=O)NC1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
CRBN Q96SW2 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002627 0.74 SMN1; SMN2 (0.36) SMN1; SMN2
SCHEMBL25002839 0.74 KDM4E (0.47) SMN1; SMN2
SCHEMBL25001423 0.74 SMN1; SMN2 (0.36) SMN1; SMN2
SCHEMBL248285 0.72
SCHEMBL21257727 0.71 OPRM1 (0.35) SMN1; SMN2
SCHEMBL3997782 0.71 ATAD2 (0.36) SMN1; SMN2CRBNHPGD
SCHEMBL6318998 0.71
SCHEMBL1441539 0.70
SCHEMBL2392698 0.70
Hydrochloric Acid SCHEMBL31401458 0.68 NEK2 (0.35) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 EP disclosed